![Portrait of Stephen Schondelmeyer](/sites/pharmacy.umn.edu/files/2023-02/stephen.png)
All Articles: Covid-19
![Portrait of Stephen Schondelmeyer](/sites/pharmacy.umn.edu/files/2023-02/stephen.png)
Effort to define and address shortage concerns.
![labar family](/sites/pharmacy.umn.edu/files/2023-02/labar_family.png)
Work focused on hydroxychloroquine trials
![mixing hand sanitizer](/sites/pharmacy.umn.edu/files/2023-02/sanitizer.jpg)
Collaboration yields needed hand sanitizer.
![Pills and laptop close up](/sites/pharmacy.umn.edu/files/2022-12/pills-and-laptop-close-up.jpeg)
Over the past few months, a number of drugs have been under investigation to treat COVID-19 without well-established safety or data to support these claims. However, some of these unproven therapies may have underlying genetic reasons for not being effective and resulting in fatal adverse effects as found with hydroxychloroquine.
![Dr. Olihe Okoro Headshot](/sites/pharmacy.umn.edu/files/2022-08/olihr-okoro-news.png)
When the COVID-19 pandemic began it became apparent that some populations were more affected by the virus than others. Research from Olihe Okoro, PhD, MPH, researcher and professor at the College of Pharmacy, Duluth, and partnering agencies, aimed to understand how members of her own community of Duluth were affected in order to provide more effective care around COVID-19.